8RK64: A chemical probe for UCHL1

A collaboration between The Drug Discovery & Chemical Biology lab and Chemical Signaling lab from CCB lead to the developement a covalent and slow reversible inhibitor for UCHL1 that has now been made freely available for the scientific community at large.

8RK64: A chemical probe for UCHL1

Ubiquitin carboxy-terminal hydrolase L1 (UCHL1), also known as neuron-specific protein PGP9.5 (PGP9.5) or Parkinson disease 5 (PARK5), is a deubiquitinating enzyme active in neurons that constitutes 1 to 2% of the total brain proteins. UCHL1 variants have been linked with neurodegenerative disorders Parkinson's and Alzheimer's disease. In addition, high levels of UCHL1 also correlate often with cancer and especially metastasis. The function of UCHL1 activity, and its role in cancer and neurodegenerative disease is poorly understood and few UCHL1-specific, high quality, activity tools are available. This chemical probe, including a negative control and fluorescent version are now freely accessible via EUbOPEN; an Innovative Medicines Initiative (IMI) funded project to enable and unlock biology in the open.

Link to chemical probe 8RK64

Link to original publication on 8RK64

Collaborate with us

Looking for information on one of our topics, a new place to conduct your research or experienced research to join forces with?  Feel free to contact us.!

Read more